Dexcom (DXCM) Cash from Investing Activities (2010 - 2026)

Dexcom (DXCM) has 17 years of Cash from Investing Activities data on file, last reported at -$298.5 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 397.9% year-over-year to -$298.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.3 million (up 175.4% YoY) and the FY2025 annual result came in at $536.0 million, up 358.31% from the prior year.
• Cash from Investing Activities declined to -$298.5 million in Q1 2026 per DXCM's latest filing, from $306.6 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $414.9 million in Q4 2023 and bottomed at -$555.9 million in Q2 2023.
• The 5-year median for Cash from Investing Activities is -$144.9 million (2022), against an average of -$58.7 million.
• The widest annual swing landed in 2022, when Cash from Investing Activities soared 690.69%; it then tumbled 397.9% in 2026.
• Tracing DXCM's Cash from Investing Activities over 5 years: stood at -$194.1 million in 2022, then soared by 313.76% to $414.9 million in 2023, then sank by 173.2% to -$303.7 million in 2024, then surged by 200.95% to $306.6 million in 2025, then slumped by 197.36% to -$298.5 million in 2026.
• Per Business Quant, the three latest DXCM Cash from Investing Activities figures stand at -$298.5 million (Q1 2026), $306.6 million (Q4 2025), and $192.8 million (Q3 2025).

Peer Comparison